To further evaluate the effects of different interventions on survival in patients with ES‐SCLC, we performed subgroup analyses of PFS and OS in patients with ES‐SCLC treated with anti‐PD‐1 + CT versus CT and anti‐PD‐L1‐based treatment + CT versus CT. The gene discussed is CD274; the disease is small cell lung carcinoma.